Parker, Chris C ; James, Nicholas D ; Brawley, Christopher D...
https://eprints.gla.ac.uk/272789/1/272789.pdf.  , 2022

James, Nicholas D ; Clarke, Noel W ; Cook, Adrian...
James , N D , Clarke , N W , Cook , A , Ali , A , Hoyle , A P , Attard , G , Brawley , C D , Chowdhury , S , Cross , W R , Dearnaley , D P , Bono , J S , Montana , C D , Gilbert , D , Gillessen , S , Gilson , C , Jones , R J , Langley , R E , Malik , Z I , Matheson , D J , Millman , R , Parker , C C , Pugh , C , Rush , H , Russell , J M , Berthold , D R , Buckner , M L , Mason , M D , Ritchie , A WS , Birtle , A J , Brock , S J , Das , P , Ford , D , Gale , J , Grant , W , Gray , E K , Hoskin , P , Khan , M M , Manetta , C , McPhail , N J , O'Sullivan , J M , Parikh , O , Perna , C , Pezaro , C J , Protheroe , A S , Robinson , A J , Rudman , S M , Sheehan , D J , Srihari , N N , Syndikus , I , Tanguay , J , Thomas , C W , Vengalil , S , Wagstaff , J , Wylie , J P , Parmar , M KB & Sydes , M R 2022 , ' Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT002684....  , 2022

James, Nicholas D ; Clarke, Noel W ; Cook, Adrian...
https://discovery.ucl.ac.uk/id/eprint/10146905/13/Sydes_Intl%20Journal%20of%20Cancer%20-%202022%20-%20James%20-%20Abiraterone%20acetate%20plus%20prednisolone%20for%20metastatic%20patients%20starting%20hormone.pdf.  , 2022

James, Nicholas D ; Clarke, Noel W ; Cook, Adrian...
http://eprints.gla.ac.uk/269452/1/269452.pdf.  , 2022

James, Nicholas D ; Ingleby, Fiona C ; Clarke, Noel W...
https://eprints.gla.ac.uk/276500/1/276500.pdf.  , 2022

James, Nicholas D ; Ingleby, Fiona C ; Clarke, Noel W...
https://discovery.ucl.ac.uk/id/eprint/10153003/1/pkac043.pdf.  , 2022

James, Nicholas D ; Ingleby, Fiona C ; Clarke, Noel W...
James , N D , Ingleby , F C , Clarke , N W , Amos , C L , Attard , G , Brawley , C D , Chowdhury , S , Cross , W , Dearnaley , D P , Gilbert , D C , Gillessen , S , Jones , R J , Langley , R E , Macnair , A , Malik , Z I , Mason , M D , Matheson , D J , Millman , R , Parker , C C , Rush , H L , Russell , J M , Au , C , Ritchie , A W S , Mestre , R P , Ahmed , I , Birtle , A J , Brock , S J , Das , P , Ford , V A , Gray , E K , Hughes , R J , Manetta , C B , McLaren , D B , Nikapota , A D , O'Sullivan , J M , Perna , C , Peedell , C , Protheroe , A S , Sundar , S , Tanguay , J S , Tolan , S P , Wagstaff , J , Wallace , J B , Wylie , J P , Zarkar , A , Parmar , M K B & Sydes , M R 2022 , ' Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial ' , JNCI Cancer Spectrum , vol. 6 , no. 4 , pkac043 . https://doi.org/10.1093/jncics/pkac043.  , 2022

Parker, Chris C ; James, Nicholas D ; Brawley, Christopher D...
https://discovery.ucl.ac.uk/id/eprint/10149983/1/Parker-2022-PLOSMed_STAMPEDE-M1RT.pdf.  , 2022